It is fair to say that Novo Nordisk is at the forefront of the weight-loss and type 2 diabetes drug market. The company's semaglutide injection—better known by the brand names Ozempic and Wegovy—has ...

The 26-year-old was sent knockoff weight loss injections from a brand she found on Instagram Kennedy News & Media Leigh-Anne ...

Novo said supply of Wegovy and Ozempic is in good shape after the drugs were removed from the FDA’s shortage list last week.

Semaglutide has been on the FDA's shortage list since 2022, which has enabled compounding pharmacies and manufactures to make their own, unapproved versions of the drug. Novo Nordisk in October ...

Novo Nordisk’s CEO has alerted healthcare professionals about the growing risks associated with compounded semaglutide, a ...

With a gain of more than 531% over the last 12 months, shares of Viking Therapeutics (NASDAQ: VKTX) are a hot commodity, to ...

Novo Nordisk addresses safety concerns surrounding compounded versions of its weight-loss and diabetes drugs, including ...

Q3 2024 Earnings Call Transcript November 6, 2024 Operator: Good day, and thank you for standing by. Welcome to the Third Quarter 2024 Novo Nordisk A/S Earnings Conference Call. At this time, all ...

Ascendis Pharma and Novo Nordisk announced a partnership to develop cardiovascular ... from its amylin analog candidate petrelintide – which led to 8.6% mean weight loss in an early phase study.

The head of the company that makes the diabetes and obesity drugs Ozempic and Wegovy has warned that compounded versi ...

BEN Shephard awkwardly stepped in on today’s This Morning when former politician Nadine Dorries repeatedly plugged a ...